Denali Therapeutics shares owned by Candriam Luxembourg S.C.A.
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Candriam Luxembourg S.C.A.
from 13F filings
Historical chart of Candriam Luxembourg S.C.A. investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Candriam Luxembourg S.C.A.
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.7M | 358k | 21.46 |
| 2023-09-30 | $7.4M | 358k | 20.63 |
| 2023-06-30 | $11M | 358k | 29.51 |
| 2023-03-31 | $7.6M | 358k | 21.21 |
| 2022-12-31 | $10M | 358k | 27.81 |
| 2022-09-30 | $11M | 358k | 30.69 |
| 2022-06-30 | $9.5M | 323k | 29.43 |
| 2022-03-31 | $4.6M | 142k | 32.17 |
| 2021-12-31 | $6.3M | 142k | 44.60 |
| 2021-09-30 | $3.2M | 64k | 50.45 |
| 2021-06-30 | $5.0M | 64k | 78.44 |
More positions owned by Candriam Luxembourg S.C.A.
View all positions for Candriam Luxembourg S.C.A.